Brenner Max, Linge Carl P, Li Wentian, Gulko Pércio S
Laboratory of Experimental Rheumatology, Center for Genomics and Human Genetics, Feinstein Institute for Medical Research and Elmezzi Graduate School of Molecular Medicine, Manhasset, New York 11030, USA.
Arthritis Rheum. 2011 Oct;63(10):2918-29. doi: 10.1002/art.30507.
To use microarray analyses of gene expression to characterize the synovial molecular pathways regulated by the arthritis regulatory locus Cia25 and to determine how it operates to control disease severity and joint damage.
Synovial tissues from DA rats and DA.ACI(Cia25) rats obtained 21 days after induction of pristane-induced arthritis were used for RNA extraction and hybridization to Illumina RatRef-12 Expression BeadChips (22,228 genes). Genes with a P value≤0.01 and a fold difference in expression≥1.5 between DA rats and DA.ACI(Cia25) rats were considered significant.
Interleukin-1β (IL-1β) (7.4-fold), IL-6 (67-fold), Ccl2, Cxcl10, Mmp3, Mmp14, and innate immunity genes were expressed at increased levels in DA rats and at significantly lower levels in DA.ACI(Cia25) congenic rats. DA.ACI(Cia25) rats had increased expression of 10 nuclear receptor (NR) genes, including those known to interfere with NF-κB activity and cytokine expression, such as Lxra, Pparg, and Rxrg. DA.ACI(Cia25) rats also had increased expression of NR targets, suggesting increased NR activity. While Vdr was not differentially expressed, a Vdr expression signature was detected in congenic rats, along with up-regulation of mediators of vitamin D synthesis.
This is the first description of the association between increased synovial levels of NRs and arthritis protection. The expression of NRs was inversely correlated with the expression of key mediators of arthritis, suggesting reciprocally opposing effects either via NF-κB or at the genomic level in the synovial tissue. We consider that the NR signature may have an important role in maintaining synovial homeostasis and an inflammation-free tissue. These processes are regulated by the Cia25 gene and suggest a new function for this gene.
利用基因表达微阵列分析来表征由关节炎调控基因座Cia25调控的滑膜分子通路,并确定其如何控制疾病严重程度和关节损伤。
将在 pristane 诱导性关节炎诱导 21 天后获得的 DA 大鼠和 DA.ACI(Cia25)大鼠的滑膜组织用于 RNA 提取,并与 Illumina RatRef-12 表达微珠芯片(22,228 个基因)进行杂交。在 DA 大鼠和 DA.ACI(Cia25)大鼠之间,P 值≤0.01 且表达倍数差异≥1.5 的基因被认为具有显著性。
白细胞介素-1β(IL-1β)(7.4 倍)、IL-6(67 倍)、Ccl2、Cxcl10、Mmp3、Mmp14 和固有免疫基因在 DA 大鼠中表达水平升高,而在 DA.ACI(Cia25)同源大鼠中表达水平显著降低。DA.ACI(Cia25)大鼠中 10 个核受体(NR)基因的表达增加,包括那些已知可干扰 NF-κB 活性和细胞因子表达的基因,如 Lxra、Pparg 和 Rxrg。DA.ACI(Cia25)大鼠中 NR 靶标的表达也增加,表明 NR 活性增强。虽然 Vdr 没有差异表达,但在同源大鼠中检测到了 Vdr 表达特征,同时维生素 D 合成介质上调。
这是首次描述滑膜中 NR 水平升高与关节炎保护之间的关联。NR 的表达与关节炎关键介质的表达呈负相关,表明在滑膜组织中可能通过 NF-κB 或在基因组水平上存在相互对立的作用。我们认为 NR 特征可能在维持滑膜稳态和无炎症组织方面具有重要作用。这些过程受 Cia25 基因调控,并提示了该基因的新功能。